Insider trading

Period: 120 months Stock: HCA Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

39 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

39 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

39 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

39 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
39 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
39 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

39 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
18 Feb 2026
McAlevey Michael R EVP & Chief Legal & Admin Off.
Sold at will
$903.54K 1,694 at 533.37
16.1%
Not planned
11 Feb 2026
Berres Jennifer SVP & Chief Human Res. Officer
Sold at will 2×
$4.13M 8,020 at 514.58
40.1%
Not planned
11 Feb 2026
Wyatt Christopher F. SVP & Controller
Sold at will
$2.02M 4,000 at 505.00
8.3%
Not planned
3 Feb 2026
Sold at will 7×
$21.48M 42,877 at 501.04
57.1%
Sold half or more
3 Feb 2026
Cuffe Michael S. EVP and Chief Clinical Officer
Sold at will
$747.14K 1,500 at 498.09
4.8%
Not planned
5 Nov 2025
McAlevey Michael R EVP & Chief Legal & Admin Off.
Sold at will
$1.84M 3,892 at 473.79
52.7%
Sold half or more
13 May 2025
Foster Jon M EVP and COO
Sold at will
$5.80M 15,698 at 369.32
55.4%
Sold half or more
14 Feb 2025
Berres Jennifer SVP & Chief Human Res. Officer
Sold at will 2×
$3.08M 9,533 at 322.59
38.2%
Not planned
14 Nov 2024
Billington Phillip G SVP-Internal Audit Services
Sold at will
$1.36M 3,897 at 350.00
6.9%
Not planned
14 Nov 2024
Akdamar Erol R Group President
Sold at will
$1.02M 2,900 at 353.00
29.8%
Not planned
14 Nov 2024
Whalen Kathleen M SVP & Chief Ethics Officer
Sold at will
$527.68K 1,474 at 357.99
13.5%
Not planned
31 Jul 2024
Whalen Kathleen M SVP & Chief Ethics Officer
Sold at will
$1.09M 2,987 at 363.51
24.0%
Not planned
29 Jul 2024
Wyatt Christopher F. SVP & Controller
Sold at will
$1.44M 4,000 at 360.20
9.0%
Not planned
29 Jul 2024
Reiner Deborah M SVP - Mktg. & Communications
Sold at will
$1.19M 3,314 at 359.96
48.6%
Not planned
29 Jul 2024
Whalen Kathleen M SVP & Chief Ethics Officer
Sold at will
$670.89K 1,864 at 359.92
13.0%
Not planned
25 Jul 2024
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$659.33K 1,857 at 355.05
9.5%
Not planned
16 May 2024
Whalen Kathleen M SVP & Chief Ethics Officer
Sold at will
$1.05M 3,204 at 326.30
25.3%
Not planned
15 May 2024
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$607.67K 1,863 at 326.18
8.7%
Not planned
9 May 2024
Cuffe Michael S. EVP and Chief Clinical Officer
Sold at will
$2.00M 6,311 at 316.88
17.6%
Not planned
9 May 2024
Cohen Jeffrey E. SVP-Government Relations
Sold at will
$516.45K 1,650 at 313.00
24.1%
Not planned
6 May 2024
Cuffe Michael S. EVP and Chief Clinical Officer
Sold at will
$494.40K 1,600 at 309.00
4.5%
Not planned
3 May 2024
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$277.68K 890 at 312.00
4.0%
Not planned
2 May 2024
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$303.58K 973 at 312.00
4.2%
Not planned
9 Feb 2024
Whalen Kathleen M SVP & Chief Ethics Officer
Sold at will
$1.31M 4,262 at 306.21
29.4%
Not planned
6 Feb 2024
RUTHERFORD BILL B CFO and EVP
Sold at will
$1.86M 6,000 at 310.63
41.5%
Not planned
5 Feb 2024
Wyatt Christopher F. SVP & Controller
Sold at will
$1.25M 4,000 at 312.42
9.7%
Not planned
5 Feb 2024
Mosier Sammie S SVP & Chief Nurse Executive
Sold at will
$513.24K 1,645 at 312.00
17.7%
Not planned
2 Feb 2024
Wasserman Chad J SVP and CIO
Sold at will
$203.45K 652 at 312.04
69.2%
Sold half or more
31 Jan 2024
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$1.19M 3,861 at 307.00
19.5%
Not planned
31 Jan 2024
Cuffe Michael S. EVP and Chief Clinical Officer
Sold at will
$981.73K 3,200 at 306.79
11.4%
Not planned
14 Aug 2023
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$1.40M 5,204 at 269.12
20.8%
Not planned
11 Aug 2023
Cohen Jeffrey E. SVP-Government Relations
Sold at will
$405.00K 1,500 at 270.00
25.4%
Not planned
3 Aug 2023
Whalen Kathleen M SVP & Chief Ethics Officer
Sold at will
$787.32K 2,916 at 270.00
22.1%
Not planned
28 Apr 2023
Cuffe Michael S. EVP and Chief Clinical Officer
Sold at will
$3.57M 12,556 at 284.44
30.4%
Not planned
28 Apr 2023
Akdamar Erol R Group President
Sold at will
$997.50K 3,500 at 285.00
7.6%
Not planned
24 Apr 2023
Torres Kathryn A. SVP-Payer Contracting & Align.
Sold at will
$1.29M 4,473 at 288.38
16.7%
Not planned
14 Apr 2023
Paslick P. Martin SVP and CIO
Sold at will
$738.93K 2,687 at 275.00
9.8%
Not planned
10 Apr 2023
Paslick P. Martin SVP and CIO
Sold at will
$685.53K 2,539 at 270.00
9.3%
Not planned
4 Apr 2023
Paslick P. Martin SVP and CIO
Sold at will
$804.01K 3,034 at 265.00
11.0%
Not planned
Showing 1–39 of 39.